Dissolution Solutions Network

News, Stories and Commentary from the Pharma Lab

A New Paradigm for Drug Discovery

Posted on | May 16, 2013 | Comments Off

“Crowdfunding has revitalized project financing. Science is next. Crowdfunding is the newest innovation in financing, all thanks to the unprecedented access to information through the Internet.

Rare Genomics Institute is helping children with rare disease. PetrDish and Microryza are finding funding for research. Community laboratories are opening up to allow amateur scientists to test their ideas cheaply. more…

NOVARTIS AG VERSUS UNION OF INDIA

Posted on | April 2, 2013 | Comments Off

IN THE SUPREME COURT OF INDIA
CIVIL APPELLATE JURISDICTION
CIVIL APPEAL Nos. 2706-2716 OF 2013
(ARISING OUT OF SLP(C) Nos. 20539-20549 OF 2009)
NOVARTIS AG ….APPELLANT
VERSUS
UNION OF INDIA & OTHERS ….RESPONDENTS
more…

New Tools in the War on Cancer

Posted on | March 19, 2013 | Comments Off

“Every avail­able cancer drug is sus­cep­tible to resis­tance, according to Man­soor Amiji, Dis­tin­guished Pro­fessor and chair of the Depart­ment of Phar­ma­ceu­tical Sci­ences. Tumors grow more quickly than blood ves­sels, so these unruly masses of cells receive very little oxygen and nutri­ents, which means they know just how to sur­vive under harsh con­di­tions. They make minia­ture pumps to actively dispel any­thing that doesn’t serve them well (like drugs), and … more

India revokes patent on Merck & Co asthma drug

Posted on | December 12, 2012 | Comments Off

“India has revoked a patent granted to an asthma drug made by Schering Corp, later bought by U.S.-based Merck & Co (MRK.N), citing lack of invention, after Indian drugmaker Cipla Ltd (CIPL.NS) challenged an earlier decision.”

“The move is the latest in a series of patent cancellations by India, where …http://in.reuters.com/article/2012/12/11/india-merck-patent-idINDEE8BA09Y20121211

Ameridose’s 483

Posted on | November 14, 2012 | Comments Off

I just read Ameridose’s 483.

Wow! It speaks for itself.

FDA Urged to Speed Approval of Drugs

Posted on | September 28, 2012 | Comments Off

“A White House advisory body on Tuesday unveiled a plan to double the number of new prescription drugs that go on the market each year by more quickly approving drugs to treat high-risk patients.

The President’s Council of Advisors on Science and Technology urged the Food and Drug Administration to expand its use of faster drug approvals to a wider range of diseases. The council suggested the FDA could begin to approve drugs that may help only a narrow and high-risk patient population, such as people who are morbidly obese, under what the council called “special medical use” approvals.

The advisory report gave few details of what new laws or …more

« go backkeep looking »
  • Topics

  • Recent Posts

  • Pages

  • Meta

  • Network Links

    • follow me on Twitter